Clinical Trials Directory

Trials / Unknown

UnknownNCT04214782

Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10,000 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Ovarian cancer is relatively rare but fatal with an annual incidence rate of 11.8 per 100 000 and a high mortality-to-incidence ratio of \>0.6. The modest diagnostic accuracy of TVU has risen some concerns about the over-treatment.Now, with the development of artificial intelligence (AI), we may have a better chance to interpret TVU imagines with high efficiency, reproducibility and accuracy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTArtificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithmAI Enabled Transvaginal Ultrasound diagnosis for ovarian cancer

Timeline

Start date
2022-10-01
Primary completion
2023-10-01
Completion
2024-10-01
First posted
2020-01-02
Last updated
2021-10-07

Source: ClinicalTrials.gov record NCT04214782. Inclusion in this directory is not an endorsement.

Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm (NCT04214782) · Clinical Trials Directory